Development and growth of cardiac muscle tissue is controlled by a variety of intrinsic and extrinsic factors. Fetal growth is by hyperplasia, is strongly governed by inherent factors and is only slightly modified by external environmental factors. The number of cell divisions is species-dependent and normally stops shortl~after birth. Developing blood volume and pressure dictate the hypertrophic stage of normal growth, and this may be further modified by abnormal hemodynamic and humoral factors. Connective tissue, neural and vascular components of the myocardium mature along with the myocyte, and alterations in these structures profoundly affect myocyte function. Hypertrophy beyond normal growth is the response of the myocyte by increased protein synthesis to various stimuli including hemodynamic, humoral and ischemic factors. Injury to normal and hypertrophied myocardium may vary due to structural and metabolic adaptations of hypertrophied tissue, such as connective tissue proliferation, vascular supply alterations and glycolytic metabolic potential. Ischemic effects influence not only cell necrosis, but also hypertrophy and congestive myocardial failure.
INTRODUCTION
The interactions of several tissue components are important in determining how the heart grows from a primordial region in the embryo to a beating, pumping, though incompletely developed structure at birth, to the fully developed heart of the adult, and finally, how it reacts to a variety of physiologic and pathologic stimuli. The heart consists not only of the muscle cell which provides the mechanical force to pump blood, but an array of neural, vascular and connective tissue components which control its action and allow effective performance. The response of the heart to injury is, in part, dependent on the stage ofgrowth. The fetal heart, for example, is more resistant to low levels of blood oxygen than the adult heart and, because cells are normally dividing, still has the potential to respond to sublethal injury by an increase in the number of cells. The adult heart responds to sublethal injury by increased protein synthesis and myocyte hypertrophy. Wheth-er myocyte hyperplasia can be induced by injury in the adult heart is a matter of conjecture, and currently is under study in several laboratories.
Development and growth ofcardiac muscle tissue is controlled by a variety of intrinsic and extrinsic factors. Fetal growth is by hyperplasia, is strongly governed by inherent factors, but may be modified by external environmental factors. The number of cell divisions is species-dependent and normally stops shortly after birth. However, several studies have provided evidence that the hyperplastic growth phase may be modified by abnormal hemodynamic and neuro-humoral factors(l9, 21, 27, 39, 50) . Connective tissue, neural and vascular components of the myocardium mature along with the myocytes, and alterations in these structures profoundly affect myocyte function.
In the adult heart, enlargement beyond that of normal growth is the response of the myocyte by increased protein synthesis to various stimuli including hemodynamic, humoral and ischemic factors. Injury to normal and hypertrophied myocardium may vary due to structural and metabolic adaptations of hypertrophied tissue such as connective tissue proliferation, vascular supply alterations and glycolytic metabolic potential. Ischemic effects result not only in cell necrosis, but also hy-438 pertrophy and the development of congestive myocardial failure. This review will summarize the major features of structural development of the heart during fetal and neonatal growth, the effects of various stimuli on fetal and adult myocardium, the response of the normal and hypertrophied heart muscle to ischemic injury, and the factors which contribute to the development ofmyocardial failure.
NORMAL DEVELOPMENT OF CARDIAC MUSCLE
Vertebrate cardiac tissue takes its origin from the splanchnic mesoderm of the early embryo which becomes the myocardium. Endocardial tissue and the vascular components of the heart are derived from the endoderm. These tissues combine to form the primitive cardiac loop which starts to contract and pump blood during the early embryonic period, prior to development of septation. By midstage of gestation (10 days in the rat), the cardiac loop stage is completed, myofibrils become identifiable and contraction of the heart begins (18) . Myofibril development is then rapid with clearly defined fibrils present in the rat heart by 13 days gestation (Fig.  1 ). The myocytes are rapidly dividing at this stage and the heart increases in mass very rapidly during the latter stages ofgestation by the process of cellular hyperplasia. Hyperplasia normally continues until soon after birth in most species of animals, when the cells stop dividing and all further increase in cardiac mass is due to increase in cell size, or hypertrophic growth (20, 70) .
During the fetal and hyperplastic phase of myocardial growth, myocytes become progressivelymore elongated from the oval or round shape in the 12 day fetus. Alignment of myofibrils in the cell and cell elongation parallel development ofintraluminal pressure, although cells retain a roughly circular cross section throughout the period of hyperplastic growth. Isolated cardiac myocytes from a newborn animal reveal very few of the specialized features found in cells which have entered the hypertrophic phase of growth ( Fig. 2) . T-tubules are absent and intercalated disc regions are only partially developed. All components of the intercalated disc are present, including nexus regions, desmosomes and filament attachment areas, but they are generally oriented parallel to the long axis of the cell and distributed over the entire cell surface ( Fig. 3 ). Myofibrils are longitudinally oriented in the newborn animal, generally clustered at the cell periphery, and attached to the cell membrane at electron dense regions ( Fig.  4 ). Sarcomeres are clearly identified with Z-lines, A-bands and I-bands, but M-lines are not present in the center of the sarcomere. M-bands appear when the cells enter the hypertrophic growth phase.
After cell division ceases, the myofibrils assume their adult longitudinal orientation, and the attachments at the cell membrane cause the filament attachment areas to become transversely oriented. The adult structure of the cell is rapidly developed with the normal adult relationship of myofibrils, mitochondria, sarcoplasmic reticulum, T-tubules, nuclei and other components, except that full myocyte size is not reached until maturity of the animal (Fig. 5 ). The external shape of the cell develops from a simple spindle cell in the neonate to a complex structure with numerous intercalated disc regions, mainly, but not exclusively, concentrated at the cell ends. The cell cross-sectional shape changes from a circular form at birth to a complex, irregular structure to accommodate adjacent cells and blood vessels. This is easily appreciated by scanning electron microscopy ( Fig. 6 ).
CONVERSION FROM HYPERPLASTIC TO HYPERTROPHIC MYOCYTE GROWTH AND DEVELOPMENT OF MYOCYTE BINUCLEATION
The conversion from hyperplastic to hypertrophic cell growth in the neonatal animal is accompanied by a number of changes in the anatomy, physiology and biochemistry of the heart. Although immature forms ofblood vessels, nerves, and connective tissue components of the heart are present during the late fetal period, they all become fully developed and functional in the neonatal animal at the time of conversion to hypertrophic cell growth. Systolic blood pressure developed by the immature right and left ventricles at birth is approximately 20-25 mm Hg, and rapidly increases in the left ventricle to reach adult levels of over 120 mm Hg by several weeksof age. Right ventricular pressure changes very little after birth and, initially, the right ventricular mass increases at a much slower rate than that of the left ventricle. After completion ofconversion to hypertrophic growth, the mass of both ventricles increases at the same rate (11) . The fetal myocardium has a relatively high rate of glycolytic metabolism, abundant glycogen, low myosin ATPase and preponderance of the {j form of myosin isozyme, high levels ofCK-MB and M-LDH, as well as other molecular forms associated with tolerance of low levels of oxygen present in the fetus. These all change during the early neonatal period to assume the adult form, concomitant with the conversion from hyperplastic to hypertrophic growth of the myocytes.
The presence ofbi-or multinucleation of cardiac myocytes has received much attention over the last several years. It is now well established that all mammals may have 1, 2 or more nuclei in cardiac myocytes after conversion from hyperplastic to hypertrophic growth, with the preponderance of ventricular myocytes having 2 nuclei in most species (43). In the rat, nearly 90% of ventricular myocytes have 2 nuclei (13, 20) , the mouse about 60% (41), the dog 60-80% (14) and, in the pig, many cells contain 4 to as many as 16 nuclei (33) .
The process of development of multinucleation ofcardiac myocytes is due to a f i n~l nuclear division which is not followed by cellular division (20) . In species with 4 or more nuclei, there is repeated karyokinesis which is not followed by cytokinesis, accounting for the frequent observation that tritiated thymidine incorporation continues much longer than the true hyperplastic phase of myocyte growth. In the rat, which has been studied the most, tritiated thymidine may still be identified in a few myocytes at 18-21 days of age (20, 62), although cell division has virtually ceased by about 6-7 days of age (19, 20) .
We have conducted studies using neonatal rats with a variety of genetic and experimentally-induced conditions to evaluate normal and stimulated myocyte growth. Isolated myocytes were prepared by retrograde aortic perfusion of the coronary vasculature with oxygenated Joklick media containing collagenase, and the cells fixed in 2% glutaraldehyde for morphologic evaluation (13) . The percentage of binucleated cells was determined by counting H&E stained preparations, and cell volume by use of a Coulter Counter system as previously described (13) . Cell number was obtained by dividing the ventricular weight adjusted for specific gravity and volume percent ofmyocytes by the average myocyte volume from the Coulter Counter.
Isolated myocytes were prepared from neonatal Fischer-344, Wistar Kyoto (WKY) and Spontaneously Hypertensive (SHR) rats and from neonatal dogs, at selected ages to evaluate the change in cell volume and nuclear number during the period of conversion from hyperplastic to hypertrophic cell growth. At birth, myocytes in all animals had a single nucleus, but by 6 days of age in the normal rat, binucleated cells appeared, rapidly increasing to approximately 90% binucleated cells by 12-15 days of age ( Fig. 7 ). Cell volume remained constant during the first week of postnatal life, during which time the heart weight doubled. Cell volume increased after 6 days ofage ( Fig. 7 ) and, thereafter, paralleled the increase in cardiac mass. Thus, the appearance of binucleated myocytes coincides with the initiation of hypertrophic growth of cardiac myocytes. DNA production and nuclear division in single nucleated cells is nearly complete by 15 days of age, with only a few myocyte nuclei demonstrating tri-.tiated thymidine incorporation after 15 days of age in the rat (Fig. 8 ). In the dog, binucleation begins at 10-14 days of age, and is complete with 60-90% of myocytes binucleated by 6 weeks of age (14) . However, rare myocytes labeled with tritiated thymidine may still be found at 8 weeks of age (8) .
In summary, the first appearance and increase in number ofbinucleated myocytes coincides with the conversion of hyperplastic to hypertrophic cardiac growth in the neonatal animal, and may be used as a marker of this event.
CARDIAC ENLARGEMENT IN FETAL AND NEONATAL ANIMALS EXPOSED TO INCREASED WORK LoAD
It has been demonstrated many times that the response of the adult heart to an increase in work load is cardiac enlargement due to an increase in the size ofthe individual myocytes. However, in the fetal and early neonatal heart, the normal process ofgrowth is by hyperplasia. A reasonable conclusion would be that work overload during this period would lead to cardiac enlargement by increase in cell number. Several studies have suggested that hyperplastic response does indeed occur followingwork overload conditions in the neonatal animal. Fishman et al (27) found an increase in heart weight with no increase in myocyte diameter in fetal lambs with obstruction of the ventricular outflow, and Neffgen and Korecky (50) demonstrated cellular hyperplasia in postnatal volume overload induced by iron deficiency anemia in the rat. Induction of increased cellular hyperplasia, however, appears to be dependent on the model used and the timing ofthe insult .
The Spontaneously Hypertensive Rat (SHR), developed by Okamoto, has been extensively studied. Several studies have found SHR to have elevated arterial pressure at birth (17, 19, 34, 44) , which presumably is present during the fetal period as well.
We used this genetic model of hypertension and cardiac hypertrophy to evaluate the effect of pressure overload on cell proliferation during perinatal growth (19) . Heart weight ofnewborn SHR was 13% larger than newborn WKY with similar body weight. Arterial blood pressure was significantly greater at birth in the SHR compared to WKY, but was not different at 9-21 days ofage, and only again became greater in the SHR by 28 days of age and later. Cell volume at birth and 3 days of age was not different between SHR and WKY ("'" 1,500 #Lm3), increased by 30% to "' " 2,000 #Lm 3 by 6 days of age and by 15 days cell volume was ""'4,000 #Lm 3. Calculation of cell number revealed a greater number of cells in , the SHR at birth, but by 12 days of age and later, cell number was equal in SHR and WKY ( Fig. 9 ).
Evaluation of the age of development of binucleation revealed that the conversion from hyperplastic to hypertrophic growth occurred about 3 days earlier in the SHR than in WKY ( Fig. 10 ). Therefore, in SHR with increased pressure load, and possibly other humoral factors, there is an increased cardiac mass at birth due to an increased number ofcardiac myocytes. However, the total number of cell divisions in SHR is not more than in WKY, but only accelerated and is completed earlier. Byseveral weeks cells; CO = 6.8 X 10 6 ± 0.5 cells; p < 0.05). Increased cell number was present in both left and right ventricles at 28 days of age in rats exposed throughout the study period and in rats only exposed postnatally ( Fig. 11 ). Therefore, volume overload due to CO exposure during the hyperplastic growth of age when growth is by cellular hypertrophy, the entire mass increase of the heart in SHR can be accounted for by increase in cell size.
We produced volume overload in fetal rats by exposing pregnant rats to 200 ppm carbon monoxide (CO) from 7 days postconception to birth followed by raising the pups in either room air or in 200 ppm CO to 28 days of age (21) . Cardiac output has previously been shown to be increased in this model in which oxygencarrying capacity of the blood is reduced by formation ofcarboxyhemoglobin (56) .
At birth, rats exposed to CO in utero had larger right ventricles than animals kept in room air, due to an increase in cell number (air = 5.8 x 10 6 ± 0.6 RV It is also possible that a number ofother humoral and genetic factors may play a role in the determination of the number of myocytes actually produced in the heart. We have recently studied cell volume and number in the hearts oftransgenic mice which express the c-myc proto-oncogene in the heart (41) . In this animal model, only the heart has morphologic changes, consisting of approximately 50% increase in cardiac mass, involving all chambers, compared to litter-mate animals which do not carry the c-myc proto-oncogene. Using isolated myocytes from 4-6-week-old animals, cell volume was found to be 40% smaller in transgenic animals compared to wild type litter-mates, and there were 2.3 times as many cardiac myocytes in the hearts of transgenic animals.
In summary, a variety of pressure, volume and genetic stimuli applied to the heart during the fetal, hyperplastic growth phase of the heart can result in an increase in the number of myocytes at the time of birth. Whether this increased number of myocytes persists apparently depends on continuation 'of the stimulus.
CARDIAC HYPERTROPHY IN THE ADULT ANIMAL

Morphologic Changes in Physiologic and Pathologic Hypertrophy
The term "cardiac hypertrophy" is often used to indicate an increase in the size of the heart due to any cause, but, in its proper use, should be restricted to increase in cardiac mass as a result of larger myocytes. The adult heart, in contrast to the fetal and early neonatal heart, responds to an increase in work load by increasing the size of the myocytes. "Cardiomegaly" may be used to describe an enlarged heart when the mechanism is uncertain. Enlargement of the heart may occur with or without chamber dilation. The terms "eccentric" and "concentric hypertrophy" have been used to indicate cardiac enlargement in the presence and absence ofdilation, respectively. Acute dilation may occur in the absence of increased cardiac mass, but in the chronic -Left ventricular myocyte number in rats exposed throughout pregnancy and for 28 days after birth to combinations of room air or 200 ppm carbon monoxide. There was a significant increase in cell number in the left ventricle by 28 days of age in rats continuously exposed to carbon monoxide (CO CO). n = 6-9 animals per group. * = p < 0.05 compared to Air Air. (Adapted from data in reference 21.) BISHOP TOXICOLOGIC PATHOLOGY situatiori, dilation is virtually always accompanied by increase in mass.
Cardiac hypertrophy has often been referred to as physiologic or pathologic, and these are useful terms to distinguish two major categories of cardiac enlargement, which appear not to be related (9, 63, 68) . Although once considered to be a continuum with gradations of cardiac hypertrophy reflecting increasing degrees of severity of functional change, it now appears that there is clear separation between physiologic and pathologic forms of hypertrophy. Physiologic hypertrophy is the increase in cell size which occurs during normal growth, and often continues slowly into old age, or that associated with increased cardiac function within normal physiologic limits, such as that due to exercise. In the trained athlete (man or animal), there is slowed heart rate due to increased vagal tone, increased stroke volume, and moderate cardiac enlargement. Function remains normal or even increased. Structural alterations are limited to proportional cell and organelle growth. Myocardial failure does not ensue from physiologic hypertrophy.
Pathologic hypertrophy refers to the myocardium with depressed myocardial function and certain structural and biochemical abnormalities. It is a consequence ofabnormally increased functional demands, or presence of exaggerated amounts ofneural-humoral substances, which leads to exhaustion of the normal reserve capacity of the myocardium, biochemical and structural alterations, and, finally, congestive heart failure. Eventually, a state is reached when removal of the stimulus will no longer result in return to normal function. This is irreversible myocardial failure. Factors responsible for progression from reversible to irreversible pathologic hypertrophy are poorly understood.
When myocytes have entered the hypertrophic phase of growth, the response to stimuli over and above that of normal growth and maintenance is to increase cell size. It has long been noted that with a pressure overload, or afterload, there is a tendency for the wall of the ventricle to thicken and the ventricular lumen to be reduced, while with volume overload, or preload, increasing mass of the heart is accompanied by lumen dilation. The wall thickening, associated with pressure overload, was assumed to be due to an increase in cell width and the dilation of volume overload to an increase in cell length (35) . This prediction has been demonstrated to be true by the use of isolated myocytes in experimental animals with outflow tract obstruction (36, 64) or renal hypertension (65) and, in volume load studies, using arteriovenous fistulae (31) . Cell length is virtually unchanged in pressure overload, but the cross-sectional area of the cell is increased proportionate to the increase in mass. With volume overload, the change is nearly all accounted for by an increase in cell length.
Vascular Changes in Cardiac Hypertrophy
In most models of cardiac hypertrophy of less than a few months duration, the number of capillaries relative to myofibers retains the normal approximatel: I ratio. The increase in cell width of the pressure overload models results in a decrease in the capillary density, while in volume overload models with no change in cell cross-sectional area, capillary density remains unchanged, or even increased (60) . This decreased capillary density of pressure overload models results in a greater tissue area to be supplied by each capillary and has fueled speculation that distant portions of the myocyte may be deprived of sufficient oxygen and, thus, make the cell more prone to develop myocardial failure. While this increased diffusion distance theory is attractive, there is little evidence to support it. Honig and Gayeski (40) have demonstrated in skeletal muscle that oxygen is freely diffusable to all parts of the cell. Furthermore, the ability of the heart to autoregulate its blood flow would allow only a modest increase in flow to make up the deficit produced by the increased mass. It, therefore, appears unlikely that increased diffusion distance is a significant factor in development of myocardial failure, at least until a severe reduction in coronary reserve is produced.
The severely hypertrophied heart, especially if failure is present, does have a loss of coronary blood flow reserve in the subendocardial regions of the left ventricle (38, 54, 67) . While blood flow to the subendocardium is normal under resting conditions, increased demand for blood flow to the heart, either by exercise or administration of vasodilators such as adenosine or dipyridamole, identifies a deficit in the normal increase in blood flow (Fig. 12) . The mechanism for this loss ofsubendocardial coronary flow reserve is unknown, but may be related to an increase in the wall thickness, and presumably loss of compliance, of the intramyocardial resistance vessels. In several animal models, an increase in the medial mass relative to the lumen area has been demonstrated in the arterioles and small arteries ranging in size from 20-200~m in diameter (3, 4, 49) . It, therefore, appears likely that these morphologic changes in the vessel wall are at least partially responsible for the decrease in subendocardial flow reserve in chronic cardiac hypertrophy. In the presence ofsuch loss ofcoronary reserve and autoregulatory ability, the increased diffusion distance to the center of hypertrophied cells may become a significant factor in cell degeneration and necrosis.
Ultrastructural Alterations ofMyocytes in Cardiac Hypertrophy
In severe cardiac hypertrophy, especially in the presence of congestive heart failure, there is a decrease in the volume percent of mitochondria in heart muscle cells (12, 47) . Decreased volume percent mitochondria has been found in human hearts (28) as well as in several animal models, including the SHR (42, 45) , aortic banded and renal hypertensive rat (5, 6, 45, 53) , and aortic banded rabbit (32) . It is not clear whether this loss of mitochondria is responsible for the decreased energy production in the hypertrophied heart, or if it is merely a reflection of the altered metabolic state and decreased requirement for high energy phosphate production.
The hypertrophied heart often has an increase in rough endoplasmic reticulum, and Golgi bodies are often prominent. The nuclear membrane may have increased folding, and formation of tubules from the inner membrane (24) . The nucleolus is often enlarged with a ribbon-like structure, and may be multiple, typical ofcells synthesizing abundant protein. In subprimate species, polyploidy of ventricular myocytes has not been described as a feature of cardiac hypertrophy, but it is a well recognized phenomenon in the hypertrophied human heart (26, 57, 61) . In the atria, however, polyploidy of myocytes does occur in rats with compensatory hypertrophy due to myocardial infarction (51) and in rats with cardiac hypertrophy due to banding ofthe aortic arch (Fig. 13) .
Increased tortuosity and folding of the intercalated disc is present relatively early in the development of cardiac hypertrophy in several animal models including pulmonary artery stenosis of dogs (12) and SHR (42) . The surface area of the intercalated disc is increased manyfold, and loose unorganized myofilaments are frequently present within these folds, forming incompletely organized sarcomeres (Fig. 14) . The increased folds apparently provide an increased surface area for assembly of newly formed myofilaments into new sarcomeres.
Expansion of Z-line material is present in a variety of animals with experimentally induced or naturally , occurring hypertrophy and failure (10, 12, 37, 42) , as well as in hypertrophied human myocardium (23, 25) . The expanded Z-lines consist ofelectron-dense material which may be diffuse in nature or, more often, has a characteristic parallel arrangement of fibrils with an approximately 200 A spacing (Fig.   15 ). Adjacent sarcomeres may be incompletely organized, suggesting an intermediate stage of sarcomere formation. The Z-line expansions may be up to a full sarcomere in length, and may be incomplete, often revealing underlying thin filaments similar to actin. The morphologic appearance of the expanded Z-lines and surrounding sarcomeres suggests formation of new sarcomeres, but this has not been demonstrated. It does appear that the Z-line expansions are a pathologic lesion of severe cardiac hypertrophy with myocardial failure, since they are not present in compensated forms of cardiac hypertrophy.
CONNECTIVE TISSUE IN CARDIAC HYPERTROPHY
Hypertrophied human hearts and animal hearts with long-standing cardiac hypertrophy are characterized by increased amounts of connective tissue. The pathogenesis of this connective tissue is not understood. It is commonly present in hearts which have developed myocardial failure, strongly suggesting that the increased connective tissue plays a role in development of myocardial failure. In physiologic cardiac hypertrophy, increased connective tissue is not a characteristic. Increased connective tissue is not a feature of the myocardium in most types of congenital heart disease, at least prior to the time that functional failure occurs. The exception is aortic valvular or subvalvular stenosis, which is characterized by considerable increase in subendocardial connective tissue (59, 66) . Experimentally induced sudden cardiac overload, such as by banding the aorta or pulmonary artery of adult animals, results in multifocal areas of necrosis (15) heart may be perivascular, interstitial, or as focal solid scars. The perivascular form is common in models with severe hypertension, and may represent damage to the perivascular tissue by increased chronic stress, or possibly due to leakage of serum proteins through the vessel wall. The interstitial form is usually located in the subendocardial region, consists of diffuse or multifocal regions of increased collagen fibrils between the myocytes, and does not appear to be the result of myocyte loss. The focal scars, on the other hand, appear to represent healing fibrosis following loss of cardiac myocytes. These multifocal scars are usually concentrated in the inner third of the myocardium.
In animal models with gradually developing increase in workload, such as in young animals with a loose band that becomes relatively more stenotic as the animal grows, connective tissue is not present in the early stages, but does develop with time. Several such animal models with gradually increasing severity of stenosis have been reported to develop increased stainable collagen or hydroxyproline levels when examined after many weeks or months (22, 38, 69) . Studies in human hearts with hypertrophy are conflicting. Several studies of cardiac hypertrophy due to hypertension in the absence of ischemic heart disease have failed to find significant increases in hydroxyproline concentration (16, 48, 52) . However, some reports have identified a positive correlation of cardiac hypertrophy and hydroxyproline in human hearts (30) . Increased connective tissue in the heart has been identified with the presence of congestive heart failure (55) . The finding that coronary reserve is severely reduced in both human (46) and animal hearts (38) with prolonged cardiac hypertrophy and myocardial failure suggestsan imbalance between the available blood supply and the required oxygen needs of the tissue, resulting in transient ischemic damage with connective tissue response. This hypothesis, however, has yet to be substantiated.
RESPONSE OF THE HYPERTROPHIED HEART TO INJURY
There are a number of biochemical changes which Occur in the heart with pathologic hypertrophy, which are not present in exercise-induced hypertrophy. These include a shift to the fJ form of cardiac myosin heavy chain, a decrease in myosin ATPase activity, an increase in the M-forms of LDH isozymes, an increase in the MB-forms of creatine kinase isozymes, and a decrease in tissue ATP. These changes all represent a shift toward the fetal tissue type and are associated with an increase in the glycolytic potential of the tissue.
The hypertrophied heart is damaged more rapidly than control hearts when subjected to total ischemia. We (2), as well as others (7, 58) , have shown that when the hypertrophied heart is subjected to total cessation of blood flow, the time to development of ischemic contracture is shorter than in control hearts. In addition, if reflow is instituted at the time of peak contracture, functional recovery is less and release oflactate dehydrogenase, a cytoplasmic enzyme, is greater (I). On the other hand, if hearts are perfused in an isolated heart apparatus with nonoxygenated media, there is less damage in the hypertrophied heart than in control hearts. The explanation appears to be in the increased glycolytic potential of the hypertrophied heart. During total ischemia with no wash out, glycolytic byproducts accumulate at a more rapid rate in the hypertrophied heart with increased glycolytic rate than in control hearts. Lactate, hydrogen ion, and possibly other factors act to damage and destroy tissue membranes, causing cell death. In the hypoxic, but perfused heart, glycolytic metabolites are removed, and the increased ATP produced by the greater glycolytic rate in the hypertrophied heart provides a measure of . protection.
CONGESTIVE HEART FAILURE
The pathogenesis of congestive heart failure is very poorly understood and it is likely that different mechanisms are involved in different circumstances. It is apparent that wall stiffness increases, with decreased relaxation properties of the contraction process and, later, decreased systolic, or contraction indices as well (29) . Blood flow and functional changes are most pronounced in the subendocardial FIG. 14. -TEM of a dog with right ventricular hypertrophy due to chronic progressive pulmonary artery stenosis. There is increased folding of the intercalated disc with many loose myofilaments not organized into mature sarcomeres within the folds. In addition, there is increased electron dense material adjacent to or attached to the intercalated disc. Compare with Fig. 5 . Bar = 1~m. regions ofthe left ventricle (38) , corresponding with the most severe myocyte and connective tissue alterations. In view of the reported increase in wall thickness of intracoronary resistance vessels, it appears reasonable to conclude that vascular and flow changes are responsible for intermittent episodes of subendocardial ischemia, resulting in increased connective tissue response, decreased wall compliance, and eventually, the inability to adequately pump blood to meet the demands of the body. structure, function and biochemical makeup adapted to an oxygenated environment. Overload of the heart, whether due to pressure, volume or humoral factors, causes the heart to respond with increased number of cells during the fetal period, but with increased cell size in the adult. The hypertrophied heart is able to perform greater amounts of work than the normal heart, but at a decreased rate, which is metabolically more efficient. However, the hypertrophied heart has a greater susceptibility to total ischemia, probably related to more rapid build up of glycolytic byproducts. Diastolic function depreciates first, followed by systolic function loss, and eventually, myocardial failure. There is abundant evidence that hypertrophy is reversible when the stimulus is removed if advanced myocardial failure has not developed. However, there is a point of irreversible injury, not clearly defined, beyond which the heart is not able to recover. Increased connective tissue is a major component of the failing myocar-dium, and the prevention of its development in the hypertrophied heart would be a desirable event.
